Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multidomain Bedside Assessment of Short-Term Mortality and Readmission Following Unplanned Hospitalization in Patients With Metastatic Cancer: The PRO-HAND Study

NCT07167082 is registered in ClinicalTrials.gov with Ankara Etlik City Hospital as lead sponsor.

NCT NCT07167082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07167082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multidomain Bedside Assessment of Short-Term Mortality and Readmission Following Unplanned Hospitalization in Patients With Metastatic Cancer: The PRO-HAND Study
Lead sponsor
Ankara Etlik City Hospital
Phase
Observational
Overall status
Completed
Start date
December 10, 2024
Completion date
January 13, 2026
Enrollment
233 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia; cancer; sarcopenia, cancer, hospitalizations, sarcopenia